Research

Cellular

The most common adverse events in the retatrutide groups were gastrointestinal and were mostly mild to moderate in severity.

Practitioners should monitor for gastrointestinal side effects in patients treated with retatrutide.

StrongQualifiesmedium confidence
The most common adverse events in the retatrutide groups were gastrointestinal; these events were dose-related, were mostly mild to moderate in severity.
Ania M. Jastreboff et al. · New England Journal of Medicine · 2023

Why this rating

Based on a phase 2, double-blind, randomized, placebo-controlled trial design.

Source

Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

Ania M. Jastreboff et al. · New England Journal of Medicine · 2023

DOI 10.1056/nejmoa2301972

rct · n=338Cited 940×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →